CN1203804A - Ganbingkang medicine for curing liver disease - Google Patents

Ganbingkang medicine for curing liver disease Download PDF

Info

Publication number
CN1203804A
CN1203804A CN98101811A CN98101811A CN1203804A CN 1203804 A CN1203804 A CN 1203804A CN 98101811 A CN98101811 A CN 98101811A CN 98101811 A CN98101811 A CN 98101811A CN 1203804 A CN1203804 A CN 1203804A
Authority
CN
China
Prior art keywords
medicine
radix
herba
rhizoma
fructus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN98101811A
Other languages
Chinese (zh)
Inventor
刘煌清
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN98101811A priority Critical patent/CN1203804A/en
Publication of CN1203804A publication Critical patent/CN1203804A/en
Pending legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a Ganbing Kangfu Chinese medicine prescription composition for curing liver diseases, including oral capsule preparation and magnetotherapeutic medicated bag for external application. Said invented medicine composition mainly is suitable for curing virus hepatitis A, B and C and liver diseases related to virus hepatitis. It can quickly obtain therapeutic result, and its therapeutic effect is reliable, toxic side effect is less and cost is low.

Description

Ganbingkang medicine for curing liver disease
The present invention relates to a kind of hepatopathy rehabilitation medicine, relate to a kind of medicine based on the treatment hepatitis B, particularly a kind of Chinese medicine and western medicine is in conjunction with the full presciption medicine thing of internal-external therapy.
Hepatitis B is caused by hepatitis B virus (HBV), becomes the master with liver, and can cause a kind of infectious disease of multiple organ injury.This disease is widely current all over the world, and at present, the whole world has more than 20 hundred million people to infect HBV, and China has 100,000,000 human hepatitis B surface antigen positives approximately.February nineteen eighty-three, World Health Organization (WHO) spelt out, and the cause of disease of 80% hepatocarcinoma has nearly 2,000,000 chronic carriers to die from liver cirrhosis or primary hepatocarcinoma that HBV causes owing to HBV causes every year.This shows that it is still very serious public health difficult problem to the world of present China that HBV infects, even to this day, the treatment of hepatitis B does not still have generally acknowledged effect method, is classified as one of 12 big medical science tackling key problem difficult problems by World Health Organization (WHO) so far.
Traditional rehabilitation principle of existing hepatitis B still with have a rest, nutrition is main means, is aided with suitable medicine and symptomatic treatment, doctor trained in Western medicine with protect the liver, antiviral, adjusting immunity; The traditional Chinese medical science with detoxifcation, dehumidifying, soothing liver-QI invigorate blood circulation, the spleen invigorating nourishing the liver; Above-mentioned treatment and known prior art are treated the Pharmaceuticals of such disease, the many unification of its means, its curative effect is not cut really, take effect slowly, the course of treatment long drug price costliness, the patient is difficult to adhere to for a long time taking medicine.
The object of the invention provides a kind of Ganbingkang medicine for curing liver disease, and this medicine adopts multiple, full presciption medicine thing that can inside and outside associating, this medicine treatment hepatitis B instant effect, short treating period, determined curative effect, drug price is low, and the patient can adhere to taking medicine for a long time, this medicine few side effects, supporting easy to use, be convenient to promote.
For achieving the above object, the present invention by the following technical solutions: a kind of Ganbingkang medicine for curing liver disease, it comprises: treatment by oral administration of medicines medicine and external treatment medicine, the treatment by oral administration of medicines medicine comprises: convalescence capsule for hepatosis patient; The external treatment medicine comprises: hepatopathy rehabilitation external medicine magnetism bag, wherein:
(1) convalescence capsule for hepatosis patient: each component proportioning (consumption is parts by weight) wherein
0.3~0.7 part of 0.2~0.6 part of Radix Kadsurae longipedunculatae of walnut tree root bark
0.2~0.6 part of 0.2~0.6 part of Fel Ursi powder of Radix Curcumae
0.3~0.7 part of 0.2~0.6 portion of Formica fusca of Rhizoma aspidistrae luridae
0.3~0.7 part of 0.2~0.6 part of Radix Et Caulis Acanthopanacis Senticosi of Ganoderma
(2) hepatopathy rehabilitation external medicine magnetism bag, wherein each component proportioning (consumption is parts by weight)
Magnetitum 80~120 Folium Citri tangerinae 2~6 Fructus Citri Sarcodactylis 3~5
Chinaberry 2~6 Radixs Linderae 2.5~5.5 Pericarpium Citri Reticulatae Virides 2~6
The Radix Paeoniae Alba 2~6 Rhizoma Cyperis 3~5 Radix Bupleuri 2~6
Flos Chrysanthemi 3~5 Herba Paederiaes 2~6 Fructus Foeniculi 2.5~5.5
Radix Et Rhizoma Rhei 3~5 Flos Carthamis 2~6 Olibanums 3~5
Myrrha 2.5~5.5 rhizoma sparganic 3~5 Rhizoma Curcumae 2~6
Rhizoma Chuanxiong 1.5~6.5 Radix Cynanchi Paniculatis 3~5 Radixs Astragali 2~6
Radix Angelicae Sinensis 3~5 Herba Ecliptaes 2~6 Herba Epimedii 1.5~6.5
Herba Lysimachiae 3~5 Herba Hedyotidis Diffusaes 2~6 Herba Taraxacis 3~5
Fructus Gardeniae 2~6 Rhizoma Paridis 2.5~5.5 Herba Artemisiae Scopariaes 3~5
Herba Pogostemonis 3~5 Herba Eupatoriis 2~6 Rhizoma Acori Graminei 3~5
The Radix Angelicae Dahuricae 2~6 Rhizoma Et Radix Notopterygiis 3~5 Folium Artemisiae Argyis 2.5~5.5
Borneolum Syntheticum 8~12 Mentholums 8~12 mature vinegar 40~92
The walnut tree root bark is the dry root bark of juglandaceae plant semen juglandis tree in the convalescence capsule for hepatosis patient.It is principal agent that this medical instrument has detoxicating, relieving inflammation; Radix Kadsurae longipedunculatae, Radix Curcumae, Fel Ursi have dispersing liver and promoting blood circulation, liver heat removing protects the liver and is accessory drugs; It is adjuvant drug that Formica fusca, Ganoderma, Radix Et Caulis Acanthopanacis Senticosi have enhance immunity; Rhizoma aspidistrae luridae has the repair tissue cell, is messenger drug.
The preparation technology of this capsule: every Chinese medicine difference decontamination in the general side, take by weighing in the desired amount, porphyrize is crossed 120 mesh sieves, will go into capsule according to a conventional method.If this capsule adopts modern decocting in water precipitate with ethanol or the heavy method of alcohol water intaking to extract effective ingredient and also is fine by the above the capsule preparation of any pharmaceutics.Raw material Fel Ursi powder used in this capsule can replace with natural Calculus Bovis or artificial Calculus Bovis, and the consumption umber proportioning in this medicine is: 015~0.35 (consumption is parts by weight), this medicine liver heat removing guarantees identical with Fel Ursi effect purposes.This capsule has: detoxicating, relieving inflammation, soothing the liverly protect the liver, enhance immunity, promotion hepatocyte recover.
Hepatopathy rehabilitation external medicine magnetism bag amounts to 39 flavor Chinese herbal medicine and forms, the effect of every medicine is respectively in the side: Magnetitum, Folium Citri tangerinae, Fructus Citri Sarcodactylis, Fructus Toosendan, the Radix Linderae, Pericarpium Citri Reticulatae Viride, the Radix Paeoniae Alba, Rhizoma Cyperi, Radix Bupleuri, Flos Chrysanthemi, Herba Paederiae, Fructus Foeniculi, has the liver microcirculation of improvement, alleviate hepatic necrosis, promote liver cell regeneration, enhance immunity, the circulation of qi promoting soothing liver-QI, pain relieving water inflammation is main medicine altogether, it is principal agent: Radix Et Rhizoma Rhei, Flos Carthami, Olibanum, Myrrha, rhizoma sparganic, Rhizoma Curcumae, Rhizoma Chuanxiong, Radix Cynanchi Paniculati, the Radix Astragali, Radix Angelicae Sinensis, Herba Ecliptae, Herba Epimedii has blood circulation promoting and blood stasis dispelling, the compensate qi and blood negative and positive are ancillary drug, i.e. accessory drugs; Herba Lysimachiae, Herba Hedyotidis Diffusae, dandelion, Fructus Gardeniae, Rhizoma Paridis, Herba Artemisiae Scopariae, Herba Pogostemonis, Herba Eupatorii, Rhizoma Acori Graminei tool heat-clearing and toxic substances removing, promoting the function of the gallbladder to alleviate jaundice, removing dampness by means of aromatics are adjuvant drug altogether; The Radix Angelicae Dahuricae, Rhizoma Et Radix Notopterygii, Folium Artemisiae Argyi, Borneolum Syntheticum, Mentholum, mature vinegar have fragrance refreshes oneself, analgesia, warm liver easing the affected liver, the saturating flesh bone of antiinflammatory, and the effect of drawing the through sick institute of all medicines of external is messenger drug altogether.
The preparation technology of medicine magnetism bag:
1. Magnetitum (the Magnetitum the best of living) takes by weighing in the desired amount in the general side, and thin mistake 100 mesh sieves of powder are standby.
In the general side must amount mature vinegar (Shanxi mature vinegar the best) take out standby.
3. Olibanum, Myrrha, Borneolum Syntheticum, Mentholum take out in the desired amount in the general side, grind to the powder respectively, cross 100 mesh sieves, and be standby.
The cloth bag or the gauze bag of sewing it up is standby 4..
In the general side other every Chinese medicine respectively decontamination, take by weighing in the desired amount, 120 mesh sieves that ground to the powder altogether, standby.
6. at first mature vinegar in 2 is mixed with Chinese medicinal powder in 5 and the container that has sealing device of packing in place after 48 hours and take out the medicated powder drying, the back adds Magnetitum powder, frankincense powder, there is not medicated powder, in the Borneolum Syntheticum powder, the even bag of packing into of Mentholum powder blend, be worn on hepatic region or SHENQUE acupoint.
This external medicine magnetism bag has: improve liver microcirculation, alleviate hepatic necrosis, promote liver cell regeneration, enhance immunity, circulation of qi promoting soothing liver-QI, blood circulation promoting and blood stasis dispelling, heat-clearing and toxic substances removing, dampness removing jaundice eliminating, effects such as warm liver, nourishing the liver, easing the affected liver, anti-inflammatory analgesic.
Advantage of the present invention:
1. with organic conception, Chinese medicine and western medicine combination, inside and outside associating, administration simultaneously is that the theoretical direction thought of its rehabilitation and treatment is: the disease of all livers with prevention and health care, clinical, new medical science that rehabilitation three big medical science combine together, the first qi depression to blood stasis of working as, circulatory disturbance, stasis of blood resistance the liver pulse, malicious heresy is seized the opportunity invasion, the poison stasis of blood is cemented in liver and gall, the damage liver and gall, consumption is hindered healthy energy, so touching difficulty more.Internal-external therapy of the present invention, with promoting flow of QI and blood, the detoxifcation removing blood stasis, strengthening vital QI to eliminate pathogenic factors, the sick instant effect for the treatment of the liver, 7~14 days produce effects, after most of patients was treated a week, subjective symptoms disappeared substantially, and appetite is promoted, and is evident in efficacy.
2. this medicine is supporting easy, and is easy to use, and drug price is low, and painful few, side effect is little, and is safe and reliable, and the patient can adhere to taking medicine for a long time, is convenient to promote.
3. this medicine mainly is adapted to: first, second, the third three type viral hepatitis, be adapted to hepatitis B especially, and also can be used as because of the liver cirrhosis due to the hepatitis, the medicine of hepatopathys such as hepatocarcinoma.
The invention will be further described below in conjunction with embodiment:
Embodiment 1:
Preparation convalescence capsule for hepatosis patient: get walnut tree root bark 0.4g, Radix Kadsurae longipedunculatae 0.5g, Radix Curcumae 0.4g, Fel Ursi powder 0.4g, Rhizoma aspidistrae luridae 0.4g, Formica fusca 0.5g, Ganoderma 0.4g, Radix Et Caulis Acanthopanacis Senticosi 0.5g, every medicine difference decontamination in the general side, grind to the powder, cross 120 mesh sieves, mixing, through 2 hours hard capsules of packing into of 35 ℃ of cold drying as convalescence capsule for hepatosis patient, if adopt (manually) Calculus Bovis 0.25g replacement Fel Ursi also to be fine; Preparation hepatopathy rehabilitation external medicine magnetism bag: get Magnetitum 100g, Folium Citri tangerinae 4g, Fructus Citri Sarcodactylis 4g, Fructus Toosendan 4g, Radix Linderae 4g, Pericarpium Citri Reticulatae Viride 4g, Radix Paeoniae Alba 4g, Rhizoma Cyperi 4g, Radix Bupleuri 4g, Flos Chrysanthemi 4g, Herba Paederiae 4g, Fructus Foeniculi 4g, Radix Et Rhizoma Rhei 4g, Flos Carthami 4g, Olibanum 4g, Myrrha 4g, rhizoma sparganic 4g, Rhizoma Curcumae 4g, Rhizoma Chuanxiong 4g, Radix Cynanchi Paniculati 4g, Radix Astragali 4g, Radix Angelicae Sinensis 4g, Herba Ecliptae 4g, Herba Epimedii 4g, Herba Lysimachiae 4g, Herba Hedyotidis Diffusae 4g, Herba Taraxaci 4g, Fructus Gardeniae 4g, Rhizoma Paridis 4g, Herba Artemisiae Scopariae 4g, Herba Pogostemonis 4g, Herba Eupatorii 4g, Rhizoma Acori Graminei 4g, Radix Angelicae Dahuricae 4g, Rhizoma Et Radix Notopterygii 4g, Folium Artemisiae Argyi 4g, Borneolum Syntheticum 10g, Mentholum 10g, mature vinegar 66g, prepare in the bag of packing into as hepatopathy rehabilitation external medicine magnetism bag by above-mentioned preparation method.
Medicine for external use in above-mentioned is supporting as Ganbingkang medicine for curing liver disease, be used for the treatment of three type viral hepatitis, liver cirrhosis, hepatocarcinoma, described interior medicine for external use is used, at first oral convalescence capsule for hepatosis patient is worn on hepatic region or SHENQUE acupoint with hepatopathy rehabilitation external medicine magnetism bag subsequently.

Claims (2)

1. Ganbingkang medicine for curing liver disease is characterized in that it comprises: treatment by oral administration of medicines medicine and external treatment medicine, and described treatment by oral administration of medicines medicine comprises: convalescence capsule for hepatosis patient; Described external treatment medicine comprises: hepatopathy rehabilitation external medicine magnetism bag, wherein:
(1) convalescence capsule for hepatosis patient: each component proportioning (consumption is parts by weight) wherein
0.3~0.7 part of 0.2~0.6 part of Radix Kadsurae longipedunculatae of walnut tree root bark
0.2~0.6 part of 0.2~0.6 part of Fel Ursi powder of Radix Curcumae
0.2~0.6 portion of Formica fusca 0.3~0.7 of Rhizoma aspidistrae luridae
0.3~0.7 part of 0.2~0.6 part of Radix Et Caulis Acanthopanacis Senticosi of Ganoderma
(2) hepatopathy rehabilitation external medicine magnetism bag: each component proportioning (consumption is parts by weight) wherein
Magnetitum 80~120 Folium Citri tangerinae 2~6 Fructus Citri Sarcodactylis 3~5
Fructus Toosendan 2~6 Radixs Linderae 2.5~5.5 Pericarpium Citri Reticulatae Virides 2~6
The Radix Paeoniae Alba 2~6 Rhizoma Cyperis 3~5 Radix Bupleuri 2~6
Flos Chrysanthemi 3~5 Herba Paederiaes 2~6 Fructus Foeniculi 2.5~5.5
Radix Et Rhizoma Rhei 3~5 Flos Carthamis 2~6 Olibanums 3~5
Myrrha 2.5~5.5 rhizoma sparganic 3~5 Rhizoma Curcumae 2~6
Rhizoma Chuanxiong 1.5~6.5 Radix Cynanchi Paniculatis 3~5 Radixs Astragali 2~6
Radix Angelicae Sinensis 3~5 Herba Ecliptaes 2~6 Herba Epimedii 1.5~6.5
Herba Lysimachiae 3~5 Herba Hedyotidis Diffusaes 2~6 Herba Taraxacis 3~5
Fructus Gardeniae 2~6 Rhizoma Paridis 2.5~5.5 Herba Artemisiae Scopariaes 3~5
Herba Pogostemonis 3~5 Herba Eupatoriis 2~6 Rhizoma Acori Graminei 3~5
The Radix Angelicae Dahuricae 2~6 Rhizoma Et Radix Notopterygiis 3~5 Folium Artemisiae Argyis 2.5~5.5
Borneolum Syntheticum 8~12 Mentholums 8~12 mature vinegar 40~92
2. according to the Ganbingkang medicine for curing liver disease described in claims 1; it is characterized in that: used raw material Fel Ursi powder can be (manually) bovine calculus powder in the described convalescence capsule for hepatosis patient, should the consumption parts by weight proportioning of (manually) bovine calculus powder in (1) be: 0.15~0.35.
CN98101811A 1998-05-04 1998-05-04 Ganbingkang medicine for curing liver disease Pending CN1203804A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN98101811A CN1203804A (en) 1998-05-04 1998-05-04 Ganbingkang medicine for curing liver disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN98101811A CN1203804A (en) 1998-05-04 1998-05-04 Ganbingkang medicine for curing liver disease

Publications (1)

Publication Number Publication Date
CN1203804A true CN1203804A (en) 1999-01-06

Family

ID=5216944

Family Applications (1)

Application Number Title Priority Date Filing Date
CN98101811A Pending CN1203804A (en) 1998-05-04 1998-05-04 Ganbingkang medicine for curing liver disease

Country Status (1)

Country Link
CN (1) CN1203804A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101537061B (en) * 2008-03-19 2011-03-16 北京绿源求证科技发展有限责任公司 Chinese medicine for treating liver cancer
CN102579909A (en) * 2012-03-22 2012-07-18 胡爱民 Medicament for treating chronic hepatitis
CN103736031A (en) * 2014-01-23 2014-04-23 荆霞 Drug for treating viral hepatitis type C and preparation method thereof
US8815221B2 (en) 2009-08-06 2014-08-26 Industrial Technology Research Institute Composition used for skin whitening, plant extracted skin whitening composition and composition having a skin whitening effect
CN106334158A (en) * 2016-10-17 2017-01-18 亳州学院 Traditional Chinese medicine composition for treating virus hepatitis and preparation method thereof and application

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101537061B (en) * 2008-03-19 2011-03-16 北京绿源求证科技发展有限责任公司 Chinese medicine for treating liver cancer
US8815221B2 (en) 2009-08-06 2014-08-26 Industrial Technology Research Institute Composition used for skin whitening, plant extracted skin whitening composition and composition having a skin whitening effect
CN102579909A (en) * 2012-03-22 2012-07-18 胡爱民 Medicament for treating chronic hepatitis
CN102579909B (en) * 2012-03-22 2013-07-10 胡爱民 Medicament for treating chronic hepatitis
CN103736031A (en) * 2014-01-23 2014-04-23 荆霞 Drug for treating viral hepatitis type C and preparation method thereof
CN106334158A (en) * 2016-10-17 2017-01-18 亳州学院 Traditional Chinese medicine composition for treating virus hepatitis and preparation method thereof and application

Similar Documents

Publication Publication Date Title
CN1322885C (en) Plaster medicine composition with multiple purpose for treating affection pain due to dampness
CN1257715A (en) Tincture for treating rheumatoid arthritis and its preparing process
CN102247497A (en) Chinese patent medicine for treating rheumatoid arthritis
CN103142920B (en) Traditional Chinese medicine composition for treating hepatitis B and preparation method thereof
CN1317021C (en) Chinese medicinal formulation for stopping pain for removing Bi
CN1203804A (en) Ganbingkang medicine for curing liver disease
CN102872301A (en) Anti-rheumatism medicinal liquor and using method thereof
CN103041301B (en) Traditional Chinese medicine composition for treating icterohepatitis
CN1115165C (en) Externally applied medicated wine for treating traumatic injury and rheumatism
CN103830672A (en) Traditional Chinese medicine for treating scapulohumeral periarthritis
CN1095287A (en) Abdominal protecting medicine for external use
CN1286500C (en) Medication for treating numbness of the muscles and painful joints
CN104383097A (en) Traditional Chinese medicine for treating lupus erythematosus
CN1772054A (en) Liver softening plaster and its prepn
CN103028049B (en) Traditional Chinese medicine composition for treating tinea manuum and preparation method of composition
CN115804805B (en) Traditional Chinese medicine compound composition for treating ankylosing spondylitis and external medicine bag
CN101322787B (en) Specific medicinal liquor for treating rheumatoild disease
CN1485086A (en) Peroral Chinese medicine powder for treating bone fracture and its preparing process
CN1294953C (en) External Chinese materia medica preparation for treating leucoderma
CN1698801A (en) Capsule for treating hemiplegia and rheumatism
CN105194411A (en) Formula of traditional Chinese medicine for treating scapulobumeral periarthritis
CN1294928C (en) Traditional Chinese medicine pills for treating toothache, and its prepn. method
CN101757355A (en) Traditional Chinese medicine preparation for treating infertility
CN101716257A (en) Orally taken powder and externally applied plaster for treating liver diseases
CN108175848A (en) It treats the Chinese medicine composition of arthralgia and myalgia, include its plaster and preparation method

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C57 Notification of unclear or unknown address
DD01 Delivery of document by public notice

Addressee: Liu Huangqing

Document name: payment instructions

C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C57 Notification of unclear or unknown address
DD01 Delivery of document by public notice

Addressee: Liu Huangqing

Document name: Notice of entry

C57 Notification of unclear or unknown address
DD01 Delivery of document by public notice

Addressee: Liu Huangqing

Document name: Notice of first review

C57 Notification of unclear or unknown address
DD01 Delivery of document by public notice

Addressee: Liu Huangqing

Document name: Deemed as a notice of withdrawal

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication